Regulatory Updates
🇺🇸 FDA Page 15FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global pharma regulatory policy changes, FDA, EMA, and other agency guidelines impacting drug development and market access. Stay ahead.
Showing 169–180 of 382 articles
Big Pharma's Shift to Smaller Deals Boosts Biotech Sector
Rallybio Taps Avenzo Therapeutics for Reverse Merger to Advance Oncology Pipeline
Legend Biotech Presents Promising CARVYKTI and LB2102 Data at ASCO
CDC Prioritizes Ebola Containment, Highlighting Critical Role of Clinical Trials
Asia Surges as Biopharma Innovation Hub, Driving Global Drug Approvals
DEA Reschedules Marijuana to Schedule III, Expediting Medical Access and Research
FDA Expert Panel to Review Peptide Access, Impacting Compounded Drug Market
Elite Pharma Files FDA ANDA for $26B Generic Blood Thinner, Targeting Key Anticoagulant Market
Rallybio Pursues Reverse Merger with Avenzo Therapeutics to Advance Autoimmune Pipeline
Obefazimod: Abivax Ulcerative Colitis Drug Faces Efficacy vs. Safety Scrutiny
CMS Finalizes Medicaid Work Requirement Rules, Impacting State Programs and Pharma Strategy
Medicus Pharma Ltd. to Present at Biotech Showcase 2026, Advancing SkinJect Program